Evidence map›Paper›PMID 32215017›Full record

ReviewStem cells international2020

Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis.

Selma Maacha, Heba Sidahmed, Shana Jacob, Giusy Gentilcore, Rita Calzone, Jean-Charles Grivel, Chiara Cugno

Open access · goldAbstract readReview
In one paragraph

Review in Stem cells international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed, 3 pooled it
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 3 syntheses or guidelines pooled it, 251 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Selma MaachaDeep Phenotyping Core, Sidra Medicine, Doha 26999, Qatar.
Heba SidahmedAdvanced Cell Therapy Core, Sidra Medicine, Doha 26999, Qatar.ORCID https://orcid.org/0000-0002-7211-0159
Shana JacobDeep Phenotyping Core, Sidra Medicine, Doha 26999, Qatar.
Giusy GentilcoreAdvanced Cell Therapy Core, Sidra Medicine, Doha 26999, Qatar.
Rita CalzoneAdvanced Cell Therapy Core, Sidra Medicine, Doha 26999, Qatar.
Jean-Charles GrivelDeep Phenotyping Core, Sidra Medicine, Doha 26999, Qatar.
Chiara CugnoAdvanced Cell Therapy Core, Sidra Medicine, Doha 26999, Qatar.ORCID https://orcid.org/0000-0002-1664-3030

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of the mesenchymal stromal cell- (MSC-) derived secretome is becoming increasingly intriguing from a clinical perspective due to its ability to stimulate endogenous tissue repair processes as well as its effective regulation of the immune system, mimicking the therapeutic effects produced by the MSCs. The secretome is a composite product secreted by MSC

Identifiers

PMID32215017
PMCPMC7085399
OpenAlexW3010082761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.